HealthStream, Inc. (HSTM)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$29.20-1.82%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
HealthStream grows revenue about 7% a year, backed by solid Q1 growth of 10.5%. The company keeps its profit margins stable and returns value by raising dividends and buying back shares. Management reaffirms 2026 revenue guidance near $326.5 million. The share buyback and dividend increases show strong capital allocation.
Growth could slow below analyst expectations of 6.7% revenue growth. Profit margins may compress if costs rise or competition intensifies. The stock trades at a premium with a PE of 37.4, which could pressure returns if growth disappoints.
The price is about 19% above our fair value near $24, reflecting roughly 7% revenue growth. Our view aligns with consensus growth but sees limited upside given the stretched valuation.
Breaks if: Dividend per share falls below $0.035 or buybacks cease in FY26
The company has increased its quarterly dividend to $0.035 per share.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
HSTM represents a durable compounder in the healthcare sector. The current thesis state is intact, supported by strong recent financial performance and a commitment to maintaining dividends.
The market seems to price in a neutral valuation with a slight premium compared to peers. There is an expectations gap of 0.13, indicating that some positive performance is already anticipated.
Fundamentals are likely to remain strong, given the robust earnings quality and management's commitment to reaffirming financial guidance. However, there is a near-term risk of missing expectations, particularly as the broader economic environment shows signs of weakness.
The thesis hinges on management's ability to maintain guidance and the performance of sector bellwethers. Additionally, any significant deterioration in the jobs report could negatively impact HSTM and similar companies.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
The company has authorized a share repurchase program to repurchase up to $10.0 million of outstanding shares.
Breaks if: Management cuts 2026 revenue or net income guidance
Breaks if: YoY revenue growth falls below 6.7% in FY26
Overall, HSTM's outlook is supported by solid fundamentals, but it faces elevated risks that could impact its performance. Not investment advice.